134 related articles for article (PubMed ID: 2191888)
1. Improvement with metformin in insulin internalization and processing in monocytes from NIDDM patients.
Benzi L; Trischitta V; Ciccarone A; Cecchetti P; Brunetti A; Squatrito S; Marchetti P; Vigneri R; Navalesi R
Diabetes; 1990 Jul; 39(7):844-9. PubMed ID: 2191888
[TBL] [Abstract][Full Text] [Related]
2. Defects in insulin-receptor internalization and processing in monocytes of obese subjects and obese NIDDM patients.
Trischitta V; Brunetti A; Chiavetta A; Benzi L; Papa V; Vigneri R
Diabetes; 1989 Dec; 38(12):1579-84. PubMed ID: 2684714
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of endosomal acidification in normal cells mimics the derangements of cellular insulin and insulin-receptor metabolism observed in non-insulin-dependent diabetes mellitus.
Benzi L; Cecchetti P; Ciccarone AM; Nardone A; Merola E; Maggiorelli R; Campi F; Di Cianni G; Navalesi R
Metabolism; 1997 Nov; 46(11):1259-65. PubMed ID: 9361682
[TBL] [Abstract][Full Text] [Related]
4. Delayed intracellular dissociation of the insulin-receptor complex impairs receptor recycling and insulin processing in cultured Epstein-Barr virus-transformed lymphocytes from insulin-resistant subjects.
Sesti G; D'Alfonso R; Vargas Punti MD; Tullio AN; Liu YY; Federici M; Borboni P; Marini MA; Lauro R; Fusco A
Diabetologia; 1996 Mar; 39(3):289-95. PubMed ID: 8721774
[TBL] [Abstract][Full Text] [Related]
5. Effect of metformin on carbohydrate and lipoprotein metabolism in NIDDM patients.
Wu MS; Johnston P; Sheu WH; Hollenbeck CB; Jeng CY; Goldfine ID; Chen YD; Reaven GM
Diabetes Care; 1990 Jan; 13(1):1-8. PubMed ID: 2404714
[TBL] [Abstract][Full Text] [Related]
6. Metformin normalizes insulin binding to monocytes from obese nondiabetic subjects and obese type II diabetic patients.
Trischitta V; Gullo D; Pezzino V; Vigneri R
J Clin Endocrinol Metab; 1983 Oct; 57(4):713-8. PubMed ID: 6350337
[TBL] [Abstract][Full Text] [Related]
7. Effect of obesity on insulin resistance in normal subjects and patients with NIDDM.
Ludvik B; Nolan JJ; Baloga J; Sacks D; Olefsky J
Diabetes; 1995 Sep; 44(9):1121-5. PubMed ID: 7657038
[TBL] [Abstract][Full Text] [Related]
8. Abnormal glucose transport and GLUT1 cell-surface content in fibroblasts and skeletal muscle from NIDDM and obese subjects.
Miele C; Formisano P; Condorelli G; Caruso M; Oriente F; Andreozzi F; Tocchetti CG; Riccardi G; Beguinot F
Diabetologia; 1997 Apr; 40(4):421-9. PubMed ID: 9112019
[TBL] [Abstract][Full Text] [Related]
9. Improvement of insulin-induced glucose disposal in obese patients with NIDDM after 1-wk treatment with d-fenfluramine.
Scheen AJ; Paolisso G; Salvatore T; Lefèbvre PJ
Diabetes Care; 1991 Apr; 14(4):325-32. PubMed ID: 2060435
[TBL] [Abstract][Full Text] [Related]
10. Insulin internalization into monocytes is decreased in patients with type II diabetes mellitus.
Trischitta V; Gullo D; Squatrito S; Pezzino V; Goldfine ID; Vigneri R
J Clin Endocrinol Metab; 1986 Mar; 62(3):522-8. PubMed ID: 3944236
[TBL] [Abstract][Full Text] [Related]
11. The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus.
Groop LC; Saloranta C; Shank M; Bonadonna RC; Ferrannini E; DeFronzo RA
J Clin Endocrinol Metab; 1991 Jan; 72(1):96-107. PubMed ID: 1986032
[TBL] [Abstract][Full Text] [Related]
12. NIDDM in the elderly.
Meneilly GS; Elliott T; Tessier D; Hards L; Tildesley H
Diabetes Care; 1996 Dec; 19(12):1320-5. PubMed ID: 8941457
[TBL] [Abstract][Full Text] [Related]
13. Intracellular insulin processing is altered in monocytes from patients with type II diabetes mellitus.
Trischitta V; Benzi L; Brunetti A; Cecchetti P; Marchetti P; Vigneri R; Navalesi R
J Clin Endocrinol Metab; 1987 May; 64(5):914-20. PubMed ID: 3549760
[TBL] [Abstract][Full Text] [Related]
14. Day-long integrated serum insulin and C-peptide profiles in patients with NIDDM. Correlation with urinary C-peptide excretion.
Garvey WT; Olefsky JM; Rubenstein AH; Kolterman OG
Diabetes; 1988 May; 37(5):590-9. PubMed ID: 3282946
[TBL] [Abstract][Full Text] [Related]
15. Effect of metformin on insulin-stimulated glucose turnover and insulin binding to receptors in type II diabetes.
Nosadini R; Avogaro A; Trevisan R; Valerio A; Tessari P; Duner E; Tiengo A; Velussi M; Del Prato S; De Kreutzenberg S
Diabetes Care; 1987; 10(1):62-7. PubMed ID: 3552515
[TBL] [Abstract][Full Text] [Related]
16. Intracellular defects in glucose metabolism in obese patients with NIDDM.
Kelley DE; Mokan M; Mandarino LJ
Diabetes; 1992 Jun; 41(6):698-706. PubMed ID: 1587397
[TBL] [Abstract][Full Text] [Related]
17. Acute antihyperglycemic mechanisms of metformin in NIDDM. Evidence for suppression of lipid oxidation and hepatic glucose production.
Perriello G; Misericordia P; Volpi E; Santucci A; Santucci C; Ferrannini E; Ventura MM; Santeusanio F; Brunetti P; Bolli GB
Diabetes; 1994 Jul; 43(7):920-8. PubMed ID: 8013758
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.
DeFronzo RA; Barzilai N; Simonson DC
J Clin Endocrinol Metab; 1991 Dec; 73(6):1294-301. PubMed ID: 1955512
[TBL] [Abstract][Full Text] [Related]
19. Glucose metabolism during the starved-to-fed transition in obese patients with NIDDM.
Féry F; Balasse EO
Diabetes; 1994 Dec; 43(12):1418-25. PubMed ID: 7958493
[TBL] [Abstract][Full Text] [Related]
20. Effect of exercise intensity on glucose and insulin metabolism in obese individuals and obese NIDDM patients.
Kang J; Robertson RJ; Hagberg JM; Kelley DE; Goss FL; DaSilva SG; Suminski RR; Utter AC
Diabetes Care; 1996 Apr; 19(4):341-9. PubMed ID: 8729157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
